Outcomes of 1st Remission Induction Chemotherapy in Acute Myeloid Leukemia Cytogenetic Risk Groups

BACKGROUND: Diagnostic karyotyping analysis is routinely used in acute myeloid leukemia (AML) clinics. Categorization of patients into risk stratified groups (favorable, intermediate and adverse) according to cytogenetic findings can serve as a valuable independent prognostic factor. METHOD AND MATE...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Asian Pac J Cancer Prev
Asıl Yazarlar: Zehra, Samreen, Najam, Rahela, Farzana, Tasneem, Shamsi, Tahir Sultan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: West Asia Organization for Cancer Prevention 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454667/
https://ncbi.nlm.nih.gov/pubmed/28125870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2016.17.12.5251
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller